Sumitomo Mitsui Trust Holdings Inc. Trims Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Sumitomo Mitsui Trust Holdings Inc. reduced its stake in Molina Healthcare, Inc. (NYSE:MOH) by 1.7% during the 4th quarter, Holdings Channel reports. The fund owned 152,967 shares of the company’s stock after selling 2,586 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in Molina Healthcare were worth $55,269,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Annis Gardner Whiting Capital Advisors LLC purchased a new stake in shares of Molina Healthcare in the third quarter valued at $30,000. Coppell Advisory Solutions Corp. purchased a new stake in shares of Molina Healthcare in the fourth quarter valued at $34,000. VisionPoint Advisory Group LLC lifted its position in shares of Molina Healthcare by 105.6% in the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock valued at $36,000 after acquiring an additional 57 shares in the last quarter. Friedenthal Financial purchased a new position in Molina Healthcare during the fourth quarter worth about $43,000. Finally, Brown Brothers Harriman & Co. purchased a new position in Molina Healthcare during the first quarter worth about $40,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $360.84 on Friday. Molina Healthcare, Inc. has a fifty-two week low of $266.35 and a fifty-two week high of $423.92. The business has a 50 day moving average price of $394.75 and a two-hundred day moving average price of $370.71. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.57. The firm has a market cap of $21.14 billion, a PE ratio of 19.21, a price-to-earnings-growth ratio of 1.00 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, February 7th. The company reported $4.38 EPS for the quarter, topping analysts’ consensus estimates of $4.31 by $0.07. Molina Healthcare had a return on equity of 32.34% and a net margin of 3.20%. The company had revenue of $9.05 billion for the quarter, compared to the consensus estimate of $8.35 billion. During the same quarter last year, the business posted $4.10 EPS. Molina Healthcare’s quarterly revenue was up 10.0% compared to the same quarter last year. Sell-side analysts expect that Molina Healthcare, Inc. will post 23.62 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on MOH shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, April 4th. Bank of America downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. Truist Financial increased their target price on Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a research report on Tuesday, February 20th. Wells Fargo & Company dropped their price target on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a research note on Monday. Finally, StockNews.com lowered Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 8th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $393.09.

Insiders Place Their Bets

In related news, Director Richard M. Schapiro sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Richard M. Schapiro sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total value of $401,050.00. Following the sale, the director now directly owns 11,207 shares in the company, valued at approximately $4,494,567.35. The disclosure for this sale can be found here. Insiders have sold a total of 16,711 shares of company stock valued at $6,472,517 in the last quarter. Insiders own 1.10% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.